AU Patent

AU665067B2 — Prefilled syringe

Assigned to Takeda Pharmaceutical Co Ltd · Expires 1995-12-14 · 30y expired

What this patent protects

A tubular body 1 has an injection needle at one end 1a and a plunger 2 at the other end, and a partition 3 slidable axially in the tubular body. The partition includes a front part 3a and a rear part 3b independent of each other, and as a whole dividing the interior space of the …

USPTO Abstract

A tubular body 1 has an injection needle at one end 1a and a plunger 2 at the other end, and a partition 3 slidable axially in the tubular body. The partition includes a front part 3a and a rear part 3b independent of each other, and as a whole dividing the interior space of the tubular body into a front compartment 4 and a rear compartment 5 in a sealing manner for storing dry powder P and liquid L, respectively. A bypass 6 is disposed between the compartments 4 and 5 to introduce the liquid L in the rear compartment 5 into the front compartment 4 when the partition 3 is slid under pressure provided by the plunger 2 to be adjacent to the bypass 6 whereby the substances are mixed immediately prior to injection. The liquid L can be introduced first and sterilised before the dry powder is placed in the front compartment 4. The front part 3a serves as a seal to prevent contamination of the powder with moisture. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
AU665067B2
Jurisdiction
AU
Classification
Expires
1995-12-14
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.